Page 5 - Flipbook
P. 5

Brian Rini, MD: Conflict of Interest















             ● Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Seattle


                 Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics,


                 Merck, Surface Oncology, Aravive, Exelixis, Jannsen, Pionyr






             ● Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Merck, Corvus, Surface Oncology,


                 Aravive, Alkermes, Arrowhead, Shionogi, Eisai, Nikang Therapeutics, EUSA, Athenex,

                 Allogene Therapeutics, Debiopharm







             ● Stock: PTC therapeutics
   1   2   3   4   5   6   7   8   9   10